India  
 
NewsR.in

U.S. pauses Eli Lilly antibody drug trial over safety concern

Video Credit: Reuters Studio - Duration: 01:12s - Published
U.S. pauses Eli Lilly antibody drug trial over safety concern

U.S. pauses Eli Lilly antibody drug trial over safety concern

Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a safety concern.

This report produced by Jillian Kitchener.


You Might Like


Related videos from verified sources

Regeneron says its COVID-19 drug cut patient visits [Video]

Regeneron says its COVID-19 drug cut patient visits

Regeneron said on Wednesday its coronavirus antibody cocktail - used to treat U.S. President Donald Trump - significantly reduced medical visits in a trial of nearly 800 patients. Gloria Tso reports.

Credit: Reuters - Politics     Duration: 01:56Published
Jim Cramer Says Pause in Eli Lilly Trial Is 'Very Big Deal' [Video]

Jim Cramer Says Pause in Eli Lilly Trial Is 'Very Big Deal'

Jim Cramer said investors are underestimating the potential impact of a pause in the Eli Lilly coronavirus treatment trial.

Credit: The Street     Duration: 01:17Published
FDA faults quality control at Eli Lilly plant [Video]

FDA faults quality control at Eli Lilly plant

U.S. drug inspectors uncovered serious quality control problems at an Eli Lilly pharmaceutical plant that is ramping up to manufacture one of two promising COVID-19 drugs touted by President Trump as..

Credit: Reuters Studio     Duration: 01:36Published